Imaging endpoints for clinical trials in MacTel type 2.
Daniel PauleikhoffLaurenz PauleikhoffEmily Y ChewPublished in: Eye (London, England) (2021)
The analysis of the area of photoreceptor loss on en face OCT is the most reliable imaging endpoint for treatment trials in MacTel. This method is already being used in ongoing randomized trials.